Koers Shandong Buchang Pharmaceuticals Co., Ltd.
Aandelen
603858
CNE100002FV6
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,85 CNY | -7,26% | -5,20% | -6,82% |
Omzet 2022 | 14,95 mld. 2,06 mld. 1,93 mld. | Omzet 2023 | 13,25 mld. 1,83 mld. 1,71 mld. | Marktkapitalisatie | 18,81 mld. 2,6 mld. 2,43 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1,66 mld. -229 mln. -214 mln. | Nettowinst (verlies) 2023 | 319 mln. 44,02 mln. 41,18 mln. | EV/omzet 2022 | 1,58 x |
Nettoschuld 2022 | 422 mln. 58,22 mln. 54,45 mln. | Nettoschuld 2023 | 2,1 mld. 290 mln. 272 mln. | EV/omzet 2023 | 1,58 x |
K/w-verhouding 2022 |
-14
x | K/w-verhouding 2023 |
59
x | Werknemers | 8.491 |
Dividendrendement 2022 |
4,57% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 40,74% |
1 dag | -7,26% | ||
1 week | -5,20% | ||
Lopende maand | -5,32% | ||
1 maand | -5,20% | ||
3 maanden | -0,88% | ||
6 maanden | -5,93% | ||
Lopend jaar | -6,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bao Cai Wang
DFI | Director of Finance/CFO | 60 | 11-03-12 |
Chao Zhao
PSD | President | 56 | 11-03-12 |
Xi Fang Wang
CTO | Chief Tech/Sci/R&D Officer | 65 | 26-03-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tao Zhao
CHM | Chairman | 58 | 11-03-12 |
Chun Yi Li
BRD | Director/Board Member | 59 | 11-03-12 |
Yu Gao
BRD | Director/Board Member | 50 | 11-03-12 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.41% | 2 M€ | -16,59% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 15,85 | -7,26% | 27 112 960 |
25-04-24 | 17,09 | +1,06% | 5 629 871 |
24-04-24 | 16,91 | -0,70% | 5 043 206 |
23-04-24 | 17,03 | +1,19% | 5 884 721 |
22-04-24 | 16,83 | +0,66% | 5 572 565 |
slotkoers Shanghai S.E., 26 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,82% | 2,42 mld. | |
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
+0,09% | 1,65 mld. | |
-12,97% | 1,53 mld. | |
+33,40% | 1,38 mld. |